Appointment of Dr. Werner Ponikwar as CEO of thyssenkrupp nucera extended by five years

Dr. Stefan Hahn to become new CFO

09-Jan-2025

The Supervisory Board of thyssenkrupp nucera Management AG resolved to extend the existing CEO contract with Dr. Werner Ponikwar by a further five years until July 2030. In addition, the Supervisory Board decided to appoint Dr. Stefan Hahn as new CFO starting from March 1, 2025. Dr. Stefan Hahn will succeed Dr. Arno Pfannschmidt, who would reach the age limit of 65 years during an extended term. Both decisions were taken unanimously. In addition, the position of CTO will change, since Fulvio Federico has informed the Supervisory Board of his wish to step down from the Management Board for personal reasons. The Supervisory Board has initiated an orderly succession process for the position of CTO. Fulvio Federico will advise the company during the transition phase and ensure a smooth handover.

“Werner Ponikwar has been driving the development of thyssenkrupp nucera as a strong player in the hydrogen market in recent years. Under his leadership, the company successfully completed the IPO in July 2023, established itself in the dynamic and evolving hydrogen market and brought high-technology products to market. His strategic vision and commitment to innovation have been pivotal for thyssenkrupp nucera’s growth journey and we are looking forward to continuing our trusting collaboration”, says Dr. Volkmar Dinstuhl, Chairman of the Supervisory Board.

Dr. Stefan Hahn joins as new CFO of thyssenkrupp nucera from thyssenkrupp AG, where he has held various senior positions in the Finance & Controlling department, most recently as interim CFO for the Business Unit Polysius and Head of Controlling, Accounting and Risk of the Business Segment Decarbon Technologies. He has also served as CFO of the Business Unit Automation Engineering.

“Stefan Hahn is an accomplished financial expert with an impressive track record. We look forward to the collaboration and wish him every success in his new role,” says Dr. Volkmar Dinstuhl, Chairman of the Supervisory Board. “We would also like to express our heartfelt thanks to the leadership and contributions of Arno Pfannschmidt and Fulvio Federico, who were instrumental for our success in the last years. Both have shaped the strategy and growth of thyssenkrupp nucera and accompanied the development of our company from a Group entity to a technologically leading, fast-growing and profitable standalone business that is now publicly listed. We wish them all the best for their futures.”

https://www.chemeurope.com/en/news/1185263/appointment-of-dr-werner-ponikwar-as-ceo-of-thyssenkrupp-nucera-extended-by-five-years.html